Venus Remedies: Statement Of Investor Complaints For The Quarter Ended September 2022 | Value Research

Best Funds for 2023: Handpicked Mutual Funds to build a winning portfolio.
(₹1,499 ₹999)

Buy Now Buy Now right-arrow

Venus Remedies: Statement Of Investor Complaints For The Quarter Ended September 2022

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter
0880
Name of the Signatory :- Neha
Designation :- Company Secretary and Compliance Officer


Other Categories